CCL

Összesen 12 találat.
#/oldal:
Részletezés:
Rendezés:

1.

001-es BibID:BIBFORM005896
Első szerző:Bajnok László (belgyógyász)
Cím:Relationship of serum resistin level of traits of metabolic syndrome and serum paraoxonase 1 activity in a population with a broad range of body mass index / Bajnok L., Seres I., Varga Zs., Jeges S., Peti A., Karányi Zs., Juhász A., Csongrádi É., Mezősi E., Nagy E. V., Paragh Gy.
Dátum:2008
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:Experimental and Clinical Endocrinology and Diabetes. - 116 : 10 (2008), p. 592-599. -
További szerzők:Seres Ildikó (1954-) (biokémikus) Varga Zsuzsa (1951-) (biokémikus, nephrológus) Jeges Sára Peti Attila Karányi Zsolt (1961-) (biostatisztikus, bioinformatikus) Juhász Attila (1970-) (szakorvos, klinikai mikrobiológus) Csongrádi Éva (1969-) (szakorvos) Mezősi Emese Nagy Endre V. (1957-) (belgyógyász, endokrinológus) Paragh György (1953-) (belgyógyász)
Internet cím:elektronikus változat
DOI
Borító:

2.

001-es BibID:BIBFORM073014
Első szerző:Berta Eszter (belgyógyász)
Cím:Early stage Graves' disease is uniformly accompanied by orbital immune activity even in patients who fail to develop orbithopathy during follow-up / Eszter Berta, Miklós Bodor, László Galuska, György Paragh, Annamária Erdei, Annamária Gazdag, Bernadett Ujhelyi, Ervin Berényi, Mónika Katkó, Andrea Gazsó, Endre V. Nagy
Dátum:2018
ISSN:0947-7349
Megjegyzések:Purpose. Graves' orbitopathy (GO) is a complication of Graves' disease (GD), the development of which cannot be predicted at the time of diagnosis of GD. Our aims were (i) to test if orbital 99mTc-labelled diethylenetriamine pentaacetic acid single-photon emission computer tomography (DTPA SPECT) can predict development of GO later during the course of the disease and (ii) to study whether orbital immune activity can be detected in GD patients who do not develop GO during follow-up.Methods. Fifty-four orbits of 27 patients with newly diagnosed GD were entered into the case-control study. Individuals showing signs of GO at enrolment were excluded. During the two-year follow up, eye signs were recorded every 3 months. Orbital DTPA uptakes on SPECT images were measured when entering the study and at the end of the follow-up period, or when clinical signs of GO developed, whichever occurred first.Results. During thefollow up, 6 patients (22%) were diagnosed with GO. There was no significant difference between the initial DTPA uptakes of the patients with or without later developing GO (10.45?1.72 MBq/cm vs. 9.18?1.18 MBq/cm3 respectively). However, the DTPA uptakes of both GD groups (ie. with and without GO) were higher than that of the control group (7.45?1.36 MBq/cm3, p<0.05).Conclusions. We have shown that GD is accompanied by moderate orbital immune activity in GD patients without GO, irrespective of later development of GO. Why this orbital autoimmunity remains subclinical in the majority of the cases, and progresses into clinically detectable GO in others, remains unclear.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
pajzsmirigy
endokrin orbitopathia
Megjelenés:Experimental And Clinical Endocrinology & Diabetes. - 126 : 10 (2018), p. 628-631. -
További szerzők:Bodor Miklós (1969-) (belgyógyász, endokrinológus) Galuska László (1946-) (belgyógyász, izotópdiagnoszta) Paragh György (1953-) (belgyógyász) Erdei Annamária (1976-) (belgyógyász) Gazdag Annamária (1979-) (belgyógyász) Ujhelyi Bernadett (1981-) (szemész) Berényi Ervin (1964-) (radiológus) Katkó Mónika (1980-) (biológus) Gazsó Andrea Nagy Endre V. (1957-) (belgyógyász, endokrinológus)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

3.

001-es BibID:BIBFORM041177
Első szerző:Burch, Henry B.
Cím:Thyrotropin receptor antisera for the detection of immunoreactive protein species in retroocular fibroblasts obtained from patients with Graves' ophthalmopathy / Burch, H. B., Sellitti, D., Barnes, S. G., Nagy, E. V., Bahn, R. S., Burman, K. D.
Dátum:1994
ISSN:0021-972X
Megjegyzések:Autoimmunity against the TSH receptor (hTSH-R) is known to be the proximate cause of thyroidal activation in Graves' disease, but has not been definitively linked to extrathyroidal manifestations of this disorder, such as ophthalmopathy and pretibial myxedema. In an effort to increase our knowledge concerning mechanisms responsible for Graves' ophthalmopathy, we used antiserum directed against a highly immunogenic portion of the hTSH-R (amino acids 352-367; P1) to assess the presence of this receptor or immunologically related protein in cultured human retroocular fibroblasts obtained from patients with Graves' ophthalmopathy. Immunoenzymatic and immunofluorescent studies revealed specific staining of both cytoplasmic and cell membrane-associated protein in discrete vesicles. To further evaluate the immunoreactive species present in these cells, immunoblotting experiments were performed using hTSH-R-specific antisera (anti-P1) and sera obtained from patients with Graves' disease. Several protein bands were identified using both anti-P1 and Graves' disease patient sera, including species at mol wt of 95, 71, and 18 kilodaltons, the possible significance of which is discussed. The results support the hypothesis that immunity against the hTSH-R or related proteins contributes to the ophthalmopathy of Graves' disease.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:Journal Of Clinical Endocrinology & Metabolism. - 78 : 6 (1994), p. 1384-1391. -
További szerzők:Sellitti, D. Barnes, Stephen Nagy Endre V. (1957-) (belgyógyász, endokrinológus) Bahn, R. S. Burman, Kenneth D.
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

4.

001-es BibID:BIBFORM017859
Első szerző:Gazdag Annamária (belgyógyász)
Cím:Improved endothelial function and lipid profile compensate for impaired hemostatic and inflammatory status in iatrogenic chronic subclinical hyperthyroidism of thyroid cancer patients on L-t4 therapy / Gazdag A., Nagy E. V., Burman K. D., Paragh Gy., Jenei Z.
Dátum:2010
Megjegyzések:We aimed to compare the changes of endothelial function and haemostatic, inflammatory and metabolic parameters of short-term iatrogenic hypothyroidism to the characteristics of subclinical hyperthyroidism in patients with differentiated thyroid cancer. DESIGN: Twenty four women (mean age 42.4+/-8.1 years) had undergone total thyroidectomy and radioiodine ablation in treatment for differentiated thyroid cancer. We measured serum thyroglobulin, thyroid function, plasma levels of lipid parameters, homocystine, C-reactive protein, fibrinogen, von Willebrandt factor activity (vWF), nitric oxide, as well as flow-mediated vasodilatation (FMD) and nitroglycerin-mediated vasodilatation of the brachial artery during iatrogenic hypothyroidism (TSH 89.82+/-29.36 mU/L) and again in the same patients during subclinical hyperthyroidism secondary to exogenous levothyroxine administration (TSH 0.24+/-0.11 mU/L). RESULTS: In hypothyroidism, FMD was markedly lower than in subclinical hyperthyroidism (6.79+/-4.44 vs. 14.37+/-8.33%, p<0.005). Total cholesterol (7.34+/-1.23 vs. 4.75+/-1.14 mmol/L, p<0.001), LDL-cholesterol (4.55+/-1.10 vs. 2.70+/-0.89 mmol/L, p<0.005) and homocystine (12.95+/-4.49 vs. 9.62+/-2.29 micromol/L, p<0.005) were significantly higher in hypothyroidism. There was no difference in nitroglycerin-mediated vasodilatation, blood pressure, serum triglyceride and HDL-cholesterol levels according to thyroid function. Fibrinogen (3.23+/-0.50 vs. 4.01+/-0.84 g/L, p<0.005), vWF (90.09+/-25.92 vs.130.63+/-29.97%, p<0.001), C-reactive protein (4.39+/-5.16 vs. 5.55+/-5.15 mg/L, p<0.001) and plasma nitric oxide (24.56+/-6.71 vs. 32.34+/-7.0 micromol/L, <0.005) values were significantly lower in hypothyroidism. FMD correlated in a positive manner with fibrinogen, vWF and nitrogen oxide. CONCLUSIONS: Chronic subclinical hyperthyroidism was associated with improved endothelial function and lipid profile, while haemostatic and inflammatory parameters were impaired. The two opposite mechanisms may well compensate for each other at the level of the vessel wall.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:Experimental and Clinical Endocrinology & Diabetes 118 : 6 (2010), p. 381-387. -
További szerzők:Nagy Endre V. (1957-) (belgyógyász, endokrinológus) Burman, Kenneth D. Paragh György (1953-) (belgyógyász) Jenei Zoltán (1968-) (belgyógyász)
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
DOI
Borító:

5.

001-es BibID:BIBFORM033124
035-os BibID:PMID:16025395
Első szerző:Győry Ferenc (kardiológus)
Cím:Establishment of the hu-PBL-SCID mouse model for the investigation of thyroid cancer / F. Győry, E. Mezősi, Sz. Szakáll, L. Bajnok, E. Varga, A. Borbély, A. Gazdag, I. Juhász, G. Lukács, E. V. Nagy
Dátum:2005
Megjegyzések:New experimental models of human neoplastic diseases attempt to mimic the human environment that fostered the development of disease in cancer patients. The aim of the present study was to establish a human lymphocyte-engrafted, severe combined immunodeficient (hu-PBL-SCID) mouse model to investigate thyroid cancer and to evaluate the potential use of this model for cancer immunotherapy. Thyroid neoplastic tissues were obtained from ten patients (one follicular adenoma, five papillary, one follicular, one anaplastic and two medullary cancers). One 8 x 4 x 3 millimeter sample from each tumor was cut into two pieces of identical size and transplanted into two SCID mice. In each case, one of the two mice was injected intraperitoneally with lymphocytes from the same tumor patient for the reconstitution of the human immune system (Group A), while the other animal received no lymphocytes (Group B). The engraftment of the tumors was successful in all cases. The growth rate was highly dependent on the histological type. When histologies were compared before implantation and after the removal of the implants, the characters of the tumors proved to be unchanged, except one case where an anaplastic cancer arose from a papillary tumor. Macrophages were present in all but one papillary cancer. All differentiated thyroid cancers were infiltrated by T and B lymphocytes. Lymphocytes and macrophages disappeared from 19/20 grafts by week 16. However, in one case from group A lymphocytes were detected four months after the transplantation. In another case from group A, one papillary cancer spontaneously decreased in size and disappeared. Before implantation, HLA-DR expression was detected in every papillary cancer. HLA-DR expression in the grafts was not seen in 3/5 cases by week 16. In conclusion, an animal model has been established for the investigation of human thyroid cancer, by which the analysis of anti-tumor immunity, as a postulate of immune therapy, may be possible.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
egyetemen (Magyarországon) készült közlemény
Megjelenés:Experimental and clinical endocrinology and diabetes 113 : 7 (2005), p. 359-364. -
További szerzők:Mezősi Emese Szakáll Szabolcs (1970-) jr. Bajnok László (1961-) (belgyógyász) Varga E. Borbély A. Gazdag Annamária (1979-) (belgyógyász) Juhász István (1956-) (bőrgyógyász, bőrsebész, kozmetológus, klinikai onkológus) Lukács Géza (1941-) (sebész) Nagy Endre V. (1957-) (belgyógyász, endokrinológus)
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
DOI
Borító:

6.

001-es BibID:BIBFORM072318
Első szerző:Kocsis Judit (onkológus)
Cím:First Line Sorafenib Treatment for Metastatic Medullary Thyroid Cancer : efficacy and Safety Analysis / Judit Kocsis, Éva Szekanecz, Ali Bassam, Andrea Uhlyarik, Zsuzsanna Pápai, Gábor Rubovszky, Emese Mezősi, Károly Rucz, Ildikó Garai, Endre Nagy, Iván Uray, Zsolt Horváth
Dátum:2019
Megjegyzések:Background Medullary thyroid cancer (MTC) is a rare disease,the prognosis of advanced and metastatic disease is poor andfew therapeutic options are available in this setting. Based onthe results of phase II and III studies with sorafenib in differentiatedthyroid cancer and the lack of availability of registeredtyrosine kinase inhibitors, vandetabin and cabozantinib in Hungary,we designed a uncontrolled, prospective efficacy andsafety study of patients with metastatic MTC treated with firstlinesorafenib in five Hungarian oncology centers.Methods Ten consecutive patients with progressive or symptomaticmetastatic MTC were included and started sorafenib400 mg twice a day between June 2012 and March 2016. Theprimary end point was median progression-free survival(mPFS). Secondary endpoints included disease control rate,biochemical response, symptomatic response and toxicity.Results Four patients achieved partial remission (40 %) accordingto RECIST 1.1 evaluation. Five patients had stable diseasebeyond 12 months (50 %) and one patient had progressivedisease (10 %). Median PFS was 19.1 months. The disease controlrate was 90 %. Association between radiologic responseand biochemical or symptomatic response was inconsistent.Most common side effects were Grade 1-2 fatigue (60 %),palmar-plantar erythrodysesthesia, rash/dermatitis 50-50 %,alopecia 40 %.Conclusions In our prospective case series in patients withMTC first-line sorafenib showed at least similar efficacy as inother small phase II trials and case reports. Based on comparableefficacy with registered tyrosine kinase inhibitors and it'smanageable toxicity profile, we believe that sorafenib has rolein the sequential treatment of MTC.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:Experimental and clinical endocrinology & diabetes. - 127 : 4 (2019), p. 240-246. -
További szerzők:Szekanecz Éva (1968-) (onkológus szakorvos) Bassam, Ali Uhlyarik Andrea Pápai Zsuzsanna Rubovszky Gábor Mezősi Emese Rucz Károly Garai Ildikó (1966-) (radiológus) Nagy Endre V. (1957-) (belgyógyász, endokrinológus) Uray Iván Péter (1970-) (kutatóorvos) Horváth Zsolt (1964-) (onkológus, belgyógyász, klinikai farmakológus)
Internet cím:DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

7.

001-es BibID:BIBFORM063083
Első szerző:Lábadi Árpád
Cím:Loss-of-Function Variants in a Hungarian Cohort Reveal Structural Insights on TSH Receptor Maturation and Signaling / Lábadi Árpád, Grassi, Elisa Stellaria, Gellén Balázs, Kleinau Gunnar, Biebermann Heike, Ruzsa Beáta, Gelmini, Giulia, Rideg Orsolya, Miseta Attila, Kovács Gábor L., Patócs Attila, Felszeghy Enikő, Nagy Endre V., Mezősi Emese, Persani, Luca
Dátum:2015
ISSN:0021-972X
Megjegyzések:CONTEXT:Congenital hypothyroidism (CH) is one of the most common inborn endocrine disorders with genetic background. Despite the well-established newborn CH screening program in Hungary, no systematic examination of the underlying genetic alterations has been performed as yet.OBJECTIVE:We aimed to explore TSH receptor (TSHR) mutations in a cohort of Hungarian patients with CH.PATIENTS:Eighty-five unrelated patients with permanent primary CH, all diagnosed at newborn screening, were selected.MAIN OUTCOME MEASURES:Coding exons of the TSHR gene were sequenced and evaluated together with the thyroid-specific clinical parameters. Functional features of the novel mutations were experimentally examined, and their comparative molecular models were built.RESULTS:In four patients (one heterozygous and three compound heterozygous), seven TSHR mutations were identified. Among these, N432(1.50)D and P449(2.39)L are novel missense alterations. Importantly, the N432(1.50) residue is highly conserved among G protein-coupled receptors, and its function has not been examined yet in human glycoprotein hormone receptors. Our results indicate that the N432(1.50)D mutation disrupts important, architecture-stabilizing intramolecular interactions and ultimately leads to the complete intracellular retention of the receptor. On the other hand, P449(2.39) is located in the intracellular part of the receptor, which is important in G protein coupling. The P449(2.39)L mutation results in signaling impairment, with a more profound effect on the Gq/11 pathway.CONCLUSION:TSHR mutations are common among Hungarian patients with CH. The novel genetic alterations revealed an important structural role of the N432(1.50) and the P449(2.39) residues in receptor expression and signaling, respectively.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Congenital hypothyroidism
TSH receptor
newborn CH screening program
Megjelenés:Journal Of Clinical Endocrinology & Metabolism. - 100 : 7 (2015), p. E1039-E1045. -
További szerzők:Grassi, Elisa Stellaria Gellén Balázs Kleinau, Gunnar Biebermann, Heike Ruzsa Beáta Gelmini, Giulia Rideg Orsolya Miseta Attila Kovács Gábor L. (Szeged) Patócs Attila Felszeghy Enikő Noémi (1970-) (gyermekgyógyász) Nagy Endre V. (1957-) (belgyógyász, endokrinológus) Mezősi Emese Persani, Luca
Pályázati támogatás:RF-2010-2309484
Egyéb
KL2334/2-2
Egyéb
BI 893/6-3
Egyéb
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

8.

001-es BibID:BIBFORM041175
Első szerző:Leövey András (belgyógyász)
Cím:Lymphocytes resided in the thyroid are the main source of TSH-receptor antibodies in Basedow's-Graves' disease? / Leövey A., Nagy E., Balázs G., Bakó G.
Dátum:1992
ISSN:0232-7384
Megjegyzések:The source of TSH-receptor antibodies (TRAb) in Basedow's-Graves' disease is still under debate. Previous studies by other groups had found TRAb levels in the thyroid vein higher than or equal to that in the peripheral vein. The aim of the present work was to investigate the suspected presence of this TRAb gradient in 14 Graves' patients who underwent surgery. Interestingly, in 6 patients higher levels of TRAb were measured in the antecubital vein when compared to the thyroid vein, in another 6 there was no gradient and 2 exhibited higher TRAb levels in their thyroid veins. A clear gradient of thyroid hormones in favour of the thyroid vein was also present, while no gradient of TSH, anti-thyreoglobulin and anti-microsomal antibodies, total IgG, IgA and IgM levels and no differences of the CD4+/CD8+ cell ratios were found between the two sampling sites. We conclude that cells other than lymphocytes residing in the thyroid gland must also be involved in TRAb production.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:Experimental And Clinical Endocrinology. - 99 : 3 (1992), p. 147-150. -
További szerzők:Nagy Endre V. (1957-) (belgyógyász, endokrinológus) Balázs György (1933-) (sebész) Bakó Gyula (1951-) (belgyógyász)
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
Borító:

9.

001-es BibID:BIBFORM100394
035-os BibID:(WoS)000638947700001 (Scopus)85104104056
Első szerző:Perros, Petros
Cím:The enigma of persistent symptoms in hypothyroid patients treated with levothyroxine : a narrative review / Perros Petros, Van Der Feltz-Cornelis Christina, Papini Enrico, Nagy Endre V., Weetman Anthony P., Hegedüs Laszlo
Dátum:2023
ISSN:0300-0664
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Clinical Endocrinology. - 98 : 4 (2023), p. 1-8. -
További szerzők:Van Der Feltz-Cornelis, Christina Papini, Enrico Nagy Endre V. (1957-) (belgyógyász, endokrinológus) Weetman, Anthony Peter Hegedüs László
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

10.

001-es BibID:BIBFORM017366
Első szerző:Szabó Jenő (belgyógyász, endocrinologus)
Cím:Parameters of respiratory burst and arachidonic acid metabolism in polymorphonuclear granulocytes from patients with various thyroid diseases / Szabó J., Fóris G., Mezösi E., Nagy E. V., Paragh G., Sztojka I., Leövey A.
Dátum:1996
Megjegyzések:The oxidative processes (oxygen consumption, superoxoid anion generation, arachidonic acid cascade) of human polymorphonuclear granulocytes (PMNs) obtained from patients suffering from thyroid disorders of autoimmune origin (Graves' disease and Hashimoto's thyroiditis), and non autoimmune origin (toxic adenoma) were investigated. All Graves' and toxic adenoma patients were hyperthyroid. Hashimoto's thyroiditis patients were euthyroid. Healthy age and sex matched volunteers served as controls. The results are as follows: 1) In PMNs from both hyperthyroid groups (Graves' disease and toxic adenoma), independently from the autoimmune origin of the disease, a significantly increased Antimycin A sensitive mitochondrial oxygen consumption and a slightly increased superoxide anion generation were detected. 2) In both autoimmune thyroid disease groups (Graves' disease and Hashimoto's thyroiditis)--depending on the functional state of the thyroid gland--a significantly altered intracellular killing activity was measured. 3) An increased arachidonic acid cascade--triggered by opsonized zymozan (OZ)--was detected in both autoimmune thyroid diseases. The increased arachidonic acid cascade was sensitive to phospholipase A2 inhibiting Mepacrin treatment. 4) The PMNs from both autoimmune thyroid diseases produced large amount of leukotriens (LTs)--LTC4 and LTB4--after stimulation through their Fc receptors but the synthesis of prostagalandins (PGs) has not changed. There are no data indicating local, specific effects of circulating leukotriens in the thyroid gland itself, but based on authors' data, their general, regulating role on both the endocrine-- as well as on the immune system--seems to be plausible.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:Experimental and Clinical Endocrinology & Diabetes. - 104 : 2 (1996), p. 172-176. -
További szerzők:Fóris Gabriella (1937-) (belgyógyász) Mezősi Emese Nagy Endre V. (1957-) (belgyógyász, endokrinológus) Paragh György (1953-) (belgyógyász) Sztojka Ilona Leövey András (1926-) (belgyógyász)
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
Borító:

11.

001-es BibID:BIBFORM111170
035-os BibID:(scopus)85131681495 (wos)000826451800001
Első szerző:Vardarli, Irfan
Cím:A Questionnaire Survey of German Thyroidologists on the Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients : The THESIS (Treatment of Hypothyroidism in Europe by Specialists: An International Survey) Collaborative / Vardarli Irfan, Brandenburg Tim, Hegedüs Laszlo, Attanasio Roberto, Nagy Endre V., Papini Enrico, Perros Petros, Weidemann Frank, Herrmann Ken, Führer Dagmar
Dátum:2022
ISSN:0947-7349 1439-3646
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Experimental And Clinical Endocrinology & Diabetes. - 130 : 9 (2022), p. 577-586. -
További szerzők:Brandenburg, Tim Hegedüs László Attanasio, Roberto Nagy Endre V. (1957-) (belgyógyász, endokrinológus) Papini, Enrico Perros, Petros Weidemann, Frank Herrmann, Ken Führer, Dagmar
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

12.

001-es BibID:BIBFORM105699
035-os BibID:(scopus)85138212686 (wos)000854379100001
Első szerző:Younes, Younes Ramazan
Cím:Use of thyroid hormones in hypothyroid and euthyroid patients : A THESIS questionnaire survey of UK endocrinologists / Younes Younes R., Perros Petros, Hegedüs Laszlo, Papini Enrico, Nagy Endre V., Attanasio Roberto, Negro Roberto, Field Benjamin C. T.
Dátum:2023
ISSN:0300-0664
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Clinical Endocrinology. - 98 : 2 (2023), p. 238-248. -
További szerzők:Perros, Petros Hegedüs László Papini, Enrico Nagy Endre V. (1957-) (belgyógyász, endokrinológus) Attanasio, Roberto Negro, Roberto Field, Benjamin C. T.
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Rekordok letöltése1 
Corvina könyvtári katalógus v8.2.27 © 2023 Monguz kft. Minden jog fenntartva.